ORCHARD THERAPEUTICS PLC Operating Cash Flow
ORCHARD THERAPEUTICS PLC reported Operating Cash Flow of -$81.23 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2023-11-13
- ORCHARD THERAPEUTICS PLC net cash provided by (used in) operating activities for the quarter ending 2023-09-30 was -$23.89M.
- ORCHARD THERAPEUTICS PLC net cash provided by (used in) operating activities for the quarter ending 2023-06-30 was -$27.83M.
- ORCHARD THERAPEUTICS PLC net cash provided by (used in) operating activities for the quarter ending 2023-03-31 was -$29.51M.
- ORCHARD THERAPEUTICS PLC net cash provided by (used in) operating activities for the quarter ending 2022-12-31 was -$12.08M.
- ORCHARD THERAPEUTICS PLC net cash provided by (used in) operating activities for fiscal 2022 was -$75.99M.
- ORCHARD THERAPEUTICS PLC net cash provided by (used in) operating activities for fiscal 2021 was -$125.10M.
- ORCHARD THERAPEUTICS PLC net cash provided by (used in) operating activities for fiscal 2020 was -$126.27M.
- ORCHARD THERAPEUTICS PLC net cash provided by (used in) operating activities for fiscal 2019 was -$166.13M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$23.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$51.73M derived: sum of 2 quarters · filed 2023-11-13 | -$81.23M 10-Q · filed 2023-11-13 | -$93.32M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | -$27.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$57.34M 10-Q · filed 2023-08-10 | -$69.42M derived: sum of 3 quarters · filed 2023-08-10 | -$87.35M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | -$29.51M 10-Q · filed 2023-05-15 | -$41.59M derived: sum of 2 quarters · filed 2023-05-15 | -$59.52M derived: sum of 3 quarters · filed 2023-11-13 | -$85.90M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | -$12.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$30.01M derived: sum of 2 quarters · filed 2023-11-13 | -$56.39M derived: sum of 3 quarters · filed 2023-11-13 | -$75.99M 10-K · filed 2023-03-14 |
| 2022-09-30 | -$17.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$44.30M derived: sum of 2 quarters · filed 2023-11-13 | -$63.90M 10-Q · filed 2023-11-13 | -$97.30M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$26.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$45.98M 10-Q · filed 2023-08-10 | -$79.37M derived: sum of 3 quarters · filed 2023-08-10 | -$95.78M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$19.60M 10-Q · filed 2023-05-15 | -$52.99M derived: sum of 2 quarters · filed 2023-05-15 | -$69.40M derived: sum of 3 quarters · filed 2023-05-15 | -$105.45M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$33.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$49.80M derived: sum of 2 quarters · filed 2023-03-14 | -$85.86M derived: sum of 3 quarters · filed 2023-03-14 | -$125.10M 10-K · filed 2023-03-14 |
| 2021-09-30 | -$16.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$52.46M derived: sum of 2 quarters · filed 2022-11-14 | -$91.70M 10-Q · filed 2022-11-14 | -$103.53M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$36.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$75.29M 10-Q · filed 2022-08-04 | -$87.13M derived: sum of 3 quarters · filed 2022-08-04 | -$113.56M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$39.24M 10-Q · filed 2022-05-12 | -$51.08M derived: sum of 2 quarters · filed 2022-05-12 | -$77.50M derived: sum of 3 quarters · filed 2022-05-12 | -$115.61M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$11.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$38.26M derived: sum of 2 quarters · filed 2022-03-30 | -$76.37M derived: sum of 3 quarters · filed 2022-03-30 | -$126.27M 10-K · filed 2022-03-30 |
| 2020-09-30 | -$26.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$64.54M derived: sum of 2 quarters · filed 2021-11-04 | -$114.44M 10-Q · filed 2021-11-04 | -$155.36M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$38.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$88.01M 10-Q · filed 2021-08-04 | -$128.93M derived: sum of 3 quarters · filed 2021-08-04 | -$181.03M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | -$49.90M 10-Q · filed 2021-05-13 | -$90.82M derived: sum of 2 quarters · filed 2021-05-13 | -$142.92M derived: sum of 3 quarters · filed 2021-05-13 | -$172.27M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | -$40.92M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | -$93.01M derived: sum of 2 quarters · filed 2021-03-02 | -$122.37M derived: sum of 3 quarters · filed 2021-03-02 | -$166.13M 10-K · filed 2021-03-02 |
| 2019-09-30 | -$52.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | -$81.45M derived: sum of 2 quarters · filed 2020-11-03 | -$125.21M 10-Q · filed 2020-11-03 | -$150.76M derived: sum of 4 quarters · filed 2020-11-03 |
| 2019-06-30 | -$29.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$73.12M 10-Q · filed 2020-08-06 | -$98.67M derived: sum of 3 quarters · filed 2020-08-06 | -$129.58M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | -$43.76M 10-Q · filed 2020-05-07 | -$69.31M derived: sum of 2 quarters · filed 2020-05-07 | -$100.22M derived: sum of 3 quarters · filed 2020-05-07 | -$126.95M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | -$25.55M derived: 10-K 12 month − 6-K 9 month · filed 2020-02-27 | -$56.46M derived: sum of 2 quarters · filed 2020-02-27 | -$83.19M derived: sum of 3 quarters · filed 2020-02-27 | -$97.54M 10-K · filed 2020-02-27 |
| 2018-09-30 | -$30.91M derived: 6-K 9 month − 6-K 6 month · filed 2019-11-07 | -$57.64M derived: sum of 2 quarters · filed 2019-11-07 | -$71.99M 6-K · filed 2019-11-07 | |
| 2018-06-30 | -$26.73M derived: 6-K 6 month − 6-K 3 month · filed 2019-08-08 | -$41.08M 6-K · filed 2019-08-08 | ||
| 2018-03-31 | -$14.35M 6-K · filed 2019-05-28 | |||
| 2017-12-31 | -$32.49M 10-K · filed 2020-02-27 | |||
| 2016-12-31 | -$14.57M 20-F · filed 2019-03-22 |